featured
Effect of High-Dose Anti-VEGF Therapy for Treatment-Resistant Neovascular AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Graefe's Archive for Clinical and Experimental Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration
Graefes Arch. Clin. Exp. Ophthalmol 2022 Jul 01;260(7)2239-2247, GK Broadhead, TDL Keenan, EY Chew, HE Wiley, CA CukrasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.